+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Inhibitory and regulatory binding sites on the rat brain serotonin transporter: molecular weight of the [3H]paroxetine and [3H]citalopram binding proteins



Inhibitory and regulatory binding sites on the rat brain serotonin transporter: molecular weight of the [3H]paroxetine and [3H]citalopram binding proteins



European Journal of Pharmacology 189(2-3): 129-134



Citalopram binds with high affinity to a specific binding site located on the serotonin (5-HT) transporter in 5-HT neurons. The binding affinity of [3H]citalopram was found to increase with increasing concentration of citalopram. This may be a homotropic positive allosteric effect, thus indicating the presence of an allosteric binding site for citalopram. The molecular weight of the proteins containing the high-affinity binding sites for citalopram and paroxetine, as well as the allosteric binding site for citalopram were determined by the irradiation method. The molecular weights of the three binding site proteins were found to be the same, suggesting that all three binding sites are located on the same protein molecule in the 5-HT transporter. The results support a hypothesis that the binding area for [3H]citalopram is located deeper in the transport channel than the [3H]paroxetine binding area. Thus the two high-affinity binding sites probably cover different, but overlapping, parts of the protein molecule. The allosteric binding site may be located elsewhere on the protein where it induces conformational changes of the 5-HT transporter with the result that high-affinity bound ligands get trapped in the transport channel, thereby explaining the increase in affinity.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 040450762

Download citation: RISBibTeXText

PMID: 2147655

DOI: 10.1016/0922-4106(90)90016-q


Related references

Inhibitory and regulatory binding sites on the rat brain serotonin transporter molecular weight of the tritiated paroxetine and tritiated citalopram binding proteins. European Journal of Pharmacology Molecular Pharmacology Section 3(2-3): 129-134, 1990

The serotonin transporter in rhesus monkey brain: comparison of DASB and citalopram binding sites. Nuclear Medicine and Biology 33(4): 555-563, 2006

Antidepressant binding sites in brain: autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter. Journal of Pharmacology and Experimental Therapeutics 252(1): 410-418, 1990

Affinity modulation of [3H]imipramine, [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and platelets. European Journal of Pharmacology 206(3): 243-250, 1991

(3)H] citalopram binding to serotonin transporter sites in minnow brains. Basic & Clinical Pharmacology & Toxicology 101(3): 203-210, 2007

Antidepressant binding sites in brain autoradiographic comparison of tritiated paroxetine and tritiated imipramine localization and relationship to serotonin transporter. Journal of Pharmacology & Experimental Therapeutics 252(1): 410-418, 1990

Relationship of tritiated paroxetine binding and 5 ht recognition sites on the neuronal serotonin transporter. Langer, S Z , A M Galzin And J Costentin (Ed ) Advances in The Biosciences, Vol 82 Presynaptic Receptors And Neuronal Transporters; Satellite Symposium to The Iuphar (International Union Of Pharmacology) Congress, Rouen, France, June 26-29, 1990 Xx+352p Pergamon Press: Oxford, England, Uk; Elmsford, New York, Usa Illus 231-232, 1991

Inhibition of [3H]citalopram binding to the rat brain serotonin transporter by Amaryllidaceae alkaloids. Planta Medica 72(5): 470-473, 2006

Influence of the serotonin transporter gene on anxiety traits and on the density of paroxetine binding sites in human platelets. American Journal of Medical Genetics 96(4): 536-537, 2000

Serotonin transporter gene regulatory region polymorphism , -paroxetine binding in healthy controls and alcohol dependants and its relation to impulsivity. European Neuropsychopharmacology 10(Suppl. 3): S381, 2000

A novel spirocyclic tropanyl-Δ²-isoxazoline derivative enhances citalopram and paroxetine binding to serotonin transporters as well as serotonin uptake. Bioorganic and Medicinal Chemistry 20(21): 6344-6355, 2012

Design and synthesis of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile (citalopram) analogues as novel probes for the serotonin transporter S1 and S2 binding sites. Journal of Medicinal Chemistry 56(23): 9709-9724, 2013

The S-enantiomer of citalopram increases inhibitor binding to the human serotonin transporter by an allosteric mechanism Comparison with other serotonin transporter inhibitors. European Neuropsychopharmacology 13(Suppl. 4): S215-S216, 2003

The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors. European Neuropsychopharmacology 15(2): 193-198, 2005

An association study of three polymorphism within the serotonin transporter gene with premenstrual dysphoria and density of paroxetine binding sites in human platelets. American Journal of Medical Genetics 105(7): 624, 2001